My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

DexCom, Inc. - Common Stock (NQ:DXCM)

71.63 -0.90 (-1.24%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 3, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

46 47 Next >

Prediction: This Top Growth Stock Will Outperform the Market in the Next Decade ↗

February 03, 2025

Via The Motley Fool

Deep Dive Into DexCom Stock: Analyst Perspectives (5 Ratings) ↗

February 03, 2025

Via Benzinga

Got $2,000? 2 Top Growth Stocks to Buy and Hold for Years ↗

February 03, 2025

Via The Motley Fool

For those who appreciate growth without the sticker shock, NASDAQ:DXCM is worth considering. ↗

January 31, 2025

NASDAQ:DXCM is scoring great on several growth aspects while it also shows decent health and profitability. At the same time it remains remains attractively priced.

Via Chartmill

Dexcom Schedules Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call for February 13, 2025 at 4:30 p.m. Eastern Time.

January 30, 2025

From DexCom, Inc.

Via Business Wire

Expert Outlook: DexCom Through The Eyes Of 11 Analysts ↗

January 16, 2025

Via Benzinga

Is NASDAQ:DXCM on the Verge of a Major Breakout as a Strong Growth Stock? ↗

January 16, 2025

Exploring the Growth Potential of DEXCOM INC (NASDAQ:DXCM) as It Nears a Breakout.

Via Chartmill

NASDAQ:DXCM qualifies as a high growth stock and is consolidating. ↗

December 25, 2024

DEXCOM INC (NASDAQ:DXCM) qualifies as a high growth stock and is consolidating.

Via Chartmill

Lululemon To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Thursday ↗

January 16, 2025

Via Benzinga

This Netflix Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday ↗

January 16, 2025

Via Benzinga

2 Healthcare Stocks to Buy Hand Over Fist in January ↗

January 16, 2025

Via The Motley Fool

Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2024 and Initial 2025 Outlook

January 13, 2025

From DexCom, Inc.

Via Business Wire

1 Reason to Sell DexCom Stock, and 1 Reason to Buy ↗

December 21, 2024

Via The Motley Fool

Peering Into DexCom's Recent Short Interest ↗

December 16, 2024

Via Benzinga

Key Takeaways From DexCom Analyst Ratings ↗

December 09, 2024

Via Benzinga

3 Reasons to Buy DexCom Stock Like There's No Tomorrow ↗

December 02, 2024

Via The Motley Fool

Health Tracking Is Moving To Smart Rings From Watches. Oura Leads Market. ↗

January 09, 2025

Smart rings are one of the hottest consumer electronics categories, as evidenced by exhibitors at CES 2025. Oura leads the market.

Via Investor's Business Daily

3 Beaten-Down Stocks That May Be Due for Big Comebacks in 2025 ↗

January 08, 2025

Via The Motley Fool

Dexcom to Present at 43rd Annual J.P. Morgan Healthcare Conference

January 07, 2025

From DexCom, Inc.

Via Business Wire

These Were the 5 Worst-Performing Stocks in the Nasdaq-100 in 2024 ↗

January 04, 2025

Via The Motley Fool

DEXCOM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of DexCom, Inc. - DXCM

December 21, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

Exploring the Growth Potential of NASDAQ:DXCM as It Nears a Breakout. ↗

December 02, 2024

Exploring the Growth Potential of DEXCOM INC (NASDAQ:DXCM) as It Nears a Breakout.

Via Chartmill

Dexcom Launches the First Generative AI Platform in Glucose Biosensing

December 17, 2024

From DexCom, Inc.

Via Business Wire

Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos ↗

December 02, 2024

Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.

Via Benzinga

2 Excellent Healthcare Stocks to Hold Through the Next Decade ↗

November 28, 2024

Via The Motley Fool

These Are the 5 Worst-Performing Stocks in the Nasdaq-100 With 2024 Almost Over ↗

November 26, 2024

Via The Motley Fool

2 Superior Growth Stocks to Buy Right Now If You have $1,000 to Invest ↗

November 24, 2024

Via The Motley Fool

Dexcom and ŌURA Announce Strategic Partnership

November 19, 2024

From DexCom, Inc.

Via Business Wire

Large-Cap Stocks In Trouble - Sunday, Nov. 17 ↗

November 17, 2024

Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps, along with their one-year price returns.

Via Talk Markets

Tiger Global Hedge Fund Buys Flutter Entertainment Stock, Sells DexCom ↗

November 14, 2024

Billionaire investor Chase Coleman's hedge fund, Tiger Global Management, filed its latest Form 13F on Thursday and disclosed its trading activity from the prior quarter.

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

46 47 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.